(R)-2-((tert-Butoxycarbonyl)amino)hex-5-enoic acid, 95%, 250mg

2-Thiophenecarboxamide, N-[2-(4-chloro-2-methylphenoxy)ethyl]-, 25mg

beta-Nicotinamide Adenine Dinucleotide Disodium Salt, reduced form [for Biochemical Research]100mg

ethyl 3-hydroxyquinoxaline-2-carboxylate, 95.0%, 5g

ethyl 4-(4-chlorophenoxy)-3-oxobutanoate, 95.0%, 1g

6-Chloro-2,3,4,9-tetrahydro-1H-carbazole, 95.0%, 5g

4,4'-Di-tert-butyl-2,2'-bipyridine, 95.0%, 10g

Ethyl 4-iodo-1H-pyrrole-2-carboxylate, 95.0%, 1g

1-Benzyl-1-phenylhydrazine Hydrochloride>98.0%(T)25g

5-ACETYL-2-METHYL-2H-INDAZOLE, 95.0%, 250mg

1-(3-Bromo-phenyl)-2,2,2-trifluoro-ethylamine hydrochloride, 95.0%, 5g

2-Bromo-5-iodobenzoic acid, 98.0%, 5g

6-(1-ethyl-3,5-dimethyl-1H-pyrazol-4-yl)-1,3-dimethyl-1H-pyrazolo[3,4-b]pyridine-4-carboxylic acid, 95.0%, 1g